137 related articles for article (PubMed ID: 28639889)
1. The association between RARβ and FHIT promoter methylation and the carcinogenesis of patients with cervical carcinoma: A meta-analysis.
Shu R; He J; Wu C; Gao J
Tumour Biol; 2017 Jun; 39(6):1010428317709126. PubMed ID: 28639889
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma.
Banzai C; Nishino K; Quan J; Yoshihara K; Sekine M; Yahata T; Tanaka K;
Int J Clin Oncol; 2014 Feb; 19(1):127-32. PubMed ID: 23494221
[TBL] [Abstract][Full Text] [Related]
3. [Interaction between polycyclic aromatic hydrocarbons and
Wang L; Liu XZ; Ren ZY; Ding L; Nan J; Liu CL; Song ZC; Feng MJ; Yang Q; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Aug; 38(8):1113-1117. PubMed ID: 28847065
[No Abstract] [Full Text] [Related]
4. [Interaction between abnormal expression of fragile histidine triad and methyl-CpG-binding protein 2 on cervical cancerization].
Yang Q; Li Y; Wang L; Song ZC; Feng MJ; Ding L; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 May; 39(5):689-693. PubMed ID: 29860820
[No Abstract] [Full Text] [Related]
5. Combined effects methylation of FHIT, RASSF1A and RARβ genes on non-small cell lung cancer in the Chinese population.
Li W; Deng J; Tang JX
Asian Pac J Cancer Prev; 2014; 15(13):5233-7. PubMed ID: 25040980
[TBL] [Abstract][Full Text] [Related]
6. Effect of aberrant promoter methylation of FHIT and RASSF1A genes on susceptibility to cervical cancer in a North Indian population.
Neyaz MK; Kumar RS; Hussain S; Naqvi SH; Kohaar I; Thakur N; Kashyap V; Das BC; Husain SA; Bharadwaj M
Biomarkers; 2008 Sep; 13(6):597-606. PubMed ID: 18608185
[TBL] [Abstract][Full Text] [Related]
7. Folate deficiency and FHIT hypermethylation and HPV 16 infection promote cervical cancerization.
Bai LX; Wang JT; Ding L; Jiang SW; Kang HJ; Gao CF; Chen X; Chen C; Zhou Q
Asian Pac J Cancer Prev; 2014; 15(21):9313-7. PubMed ID: 25422218
[TBL] [Abstract][Full Text] [Related]
8. Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen R; He G; Gao JX
Int J Clin Exp Pathol; 2010 May; 3(5):482-91. PubMed ID: 20606729
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation during cervical carcinogenesis.
Virmani AK; Muller C; Rathi A; Zoechbauer-Mueller S; Mathis M; Gazdar AF
Clin Cancer Res; 2001 Mar; 7(3):584-9. PubMed ID: 11297252
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
Kim H; Kwon YM; Kim JS; Lee H; Park JH; Shim YM; Han J; Park J; Kim DH
J Clin Oncol; 2004 Jun; 22(12):2363-70. PubMed ID: 15197197
[TBL] [Abstract][Full Text] [Related]
11. The effect of codon 98 of the FHIT gene on cervical cancer in Korean women.
Jee SH; Um SJ; Lee JE; Kim S; Kim JH; Lee SJ; Namkoong SE; Park JS
Int J Gynecol Cancer; 2003; 13(6):843-8. PubMed ID: 14675322
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review.
Su Y; Wang X; Li J; Xu J; Xu L
Drug Des Devel Ther; 2015; 9():5439-45. PubMed ID: 26491255
[TBL] [Abstract][Full Text] [Related]
13. Expression of selected miRNA, RARβ and FHIT genes in BALf of squamous cell lung cancer (squamous-cell carcinoma, SCC) patients: a pilot study.
Dutkowska A; Antczak A; Domańska-Senderowska D; Brzeziańska-Lasota E
Mol Biol Rep; 2019 Dec; 46(6):6593-6597. PubMed ID: 31502191
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer].
Shi HR; Wu QH; Suo ZH; Nesland JM
Ai Zheng; 2005 Jan; 24(1):7-11. PubMed ID: 15642192
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.
Geng X; Pu W; Tan Y; Lu Z; Wang A; Tan L; Chen S; Guo S; Wang J; Chen X
Oncotarget; 2017 Jan; 8(4):6845-6856. PubMed ID: 28036263
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A promoter methylation was associated with the development, progression and metastasis of cervical carcinoma: a meta-analysis with trial sequential analysis.
Zheng F; Yu H
Arch Gynecol Obstet; 2018 Feb; 297(2):467-477. PubMed ID: 29288321
[TBL] [Abstract][Full Text] [Related]
18. [Methylation status of the 5' CpG islands in FHIT gene in the plasma and tissues of cervical cancer patients].
Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
Yi Chuan; 2006 Sep; 28(9):1061-6. PubMed ID: 16963412
[TBL] [Abstract][Full Text] [Related]
19. [Interaction between fragile histidine triad methylation, protein expression and human papillomavirus 16 infection in cervical carcinogenesis].
Liu XZ; Nan J; Li J; Li Y; Ding L; Wang JT
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jun; 37(6):858-62. PubMed ID: 27346116
[TBL] [Abstract][Full Text] [Related]
20. Loss of fhit expression in invasive cervical carcinomas and intraepithelial lesions associated with invasive disease.
Connolly DC; Greenspan DL; Wu R; Ren X; Dunn RL; Shah KV; Jones RW; Bosch FX; Muñoz N; Cho KR
Clin Cancer Res; 2000 Sep; 6(9):3505-10. PubMed ID: 10999736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
